Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongzhou Lu

Showing results (1-10 of 444) with videos related to

Pageof 45
Sort By:
Bioscience Trends|January 31, 2020
Drug treatment options for the 2019-new coronavirus (2019-nCoV)Hongzhou Lu
Bioscience Trends|November 19, 2013
Combat with emerging infectious diseases: clinicians should do betterHongzhou Lu
Bioscience Trends|February 17, 2022
More effective vaccines and oral antivirals: Keys for the battle against OmicronHongzhou Lu
Intractable & Rare Diseases Research|December 16, 2015
China takes an active role in combating an Ebola outbreak: On-site observations and reflections from a Chinese healthcare providerHongzhou Lu
Bioscience Trends|September 15, 2017
Latest advances in the efficacy, tolerability, and monotherapy of integrase inhibitorsQi Tang, Hongzhou Lu
Drug Discoveries & Therapeutics|May 8, 2022
Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?Guangbin Chen, Hongzhou Lu
Bioscience Trends|January 4, 2021
Latest updates on COVID-19 vaccinesQian Li, Hongzhou Lu
Advances in Experimental Medicine and Biology|October 21, 2017
Malignancies in HIV-Infected and AIDS PatientsYongjia Ji, Hongzhou Lu
The Open AIDS Journal|March 13, 2010
Technology Development Through Pooling ARV Drug Patents: A Vision from ChinaLi Liu, Hongzhou Lu
Emerging Infectious Diseases|May 29, 2010
Pandemic (H1N1) 2009, Shanghai, ChinaYinzhong Shen, Hongzhou Lu
Pageof 45

Showing results (1-10 of 444) with videos related to

Sort By:
Pageof 45
Bioscience Trends|January 31, 2020
Drug treatment options for the 2019-new coronavirus (2019-nCoV)Hongzhou Lu
Bioscience Trends|November 19, 2013
Combat with emerging infectious diseases: clinicians should do betterHongzhou Lu
Bioscience Trends|February 17, 2022
More effective vaccines and oral antivirals: Keys for the battle against OmicronHongzhou Lu
Intractable & Rare Diseases Research|December 16, 2015
China takes an active role in combating an Ebola outbreak: On-site observations and reflections from a Chinese healthcare providerHongzhou Lu
Bioscience Trends|September 15, 2017
Latest advances in the efficacy, tolerability, and monotherapy of integrase inhibitorsQi Tang, Hongzhou Lu
Drug Discoveries & Therapeutics|May 8, 2022
Oral high-dose acetylcysteine: Effective against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)?Guangbin Chen, Hongzhou Lu
Bioscience Trends|January 4, 2021
Latest updates on COVID-19 vaccinesQian Li, Hongzhou Lu
Advances in Experimental Medicine and Biology|October 21, 2017
Malignancies in HIV-Infected and AIDS PatientsYongjia Ji, Hongzhou Lu
The Open AIDS Journal|March 13, 2010
Technology Development Through Pooling ARV Drug Patents: A Vision from ChinaLi Liu, Hongzhou Lu
Emerging Infectious Diseases|May 29, 2010
Pandemic (H1N1) 2009, Shanghai, ChinaYinzhong Shen, Hongzhou Lu
Pageof 45